KLRS
Kalaris Therapeutics, Inc.
3.20$
+1.4%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -85.5% | – | – | – | – | – | – | |
| – | – | – | +1,430.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +854.6% | +205.6% | +141.2% | -90.2% | -0.5% | +5.4% | +149.2% | |
| – | – | – | – | – | -21.7% | +280.8% | +130.2% | |
| – | +467.5% | +165.3% | +136.8% | -91.7% | -3.9% | +310.4% | -16.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +192.3% | +293.2% | -46.6% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.